ARCO Classification Criteria of Glucocorticoid-Associated Osteonecrosis of the Femoral Head

Byung Ho Yoon; Young Dong Song; Lynne C. Jones; Michael A. Mont; Quanjun Cui; Kyung Hoi Koo

doi:10.1007/978-981-97-5239-3_14

ARCO Classification Criteria of Glucocorticoid-Associated Osteonecrosis of the Femoral Head

Byung Ho Yoon, Young Dong Song, Lynne C. Jones, Michael A. Mont, Quanjun Cui, Kyung Hoi Koo

Department of Orthopedic Surgery

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Glucocorticoids are commonly used for the treatment of various medical conditions such as autoimmune diseases, inflammatory conditions, and organ transplantation [1–3]. Long-term or high-dose usage of glucocorticoids has been associated with an increased risk of osteonecrosis, particularly in the femoral head [4–8]. Since 1957, when the first case of osteonecrosis of the femoral head (ONFH) after the use of glucocorticoid was reported, many human and animal studies identified the glucocorticoid use as a leading cause of ONFH [4–12].

Original language	English
Title of host publication	Osteonecrosis, Second Edition
Publisher	Springer Singapore
Pages	123-128
Number of pages	6
ISBN (Electronic)	9789819752393
ISBN (Print)	9789819752386
DOIs	https://doi.org/10.1007/978-981-97-5239-3_14
State	Published - 1 Jan 2024

Bibliographical note

Publisher Copyright:
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2024.

Keywords

ARCO
Criteria
Delphi
Femoral head
Glucocorticoid
Osteonecrosis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-981-97-5239-3_14

Cite this

@inbook{1b5a39620cb7411eba1a21fbe24f195c,

title = "ARCO Classification Criteria of Glucocorticoid-Associated Osteonecrosis of the Femoral Head",

abstract = "Glucocorticoids are commonly used for the treatment of various medical conditions such as autoimmune diseases, inflammatory conditions, and organ transplantation [1–3]. Long-term or high-dose usage of glucocorticoids has been associated with an increased risk of osteonecrosis, particularly in the femoral head [4–8]. Since 1957, when the first case of osteonecrosis of the femoral head (ONFH) after the use of glucocorticoid was reported, many human and animal studies identified the glucocorticoid use as a leading cause of ONFH [4–12].",

keywords = "ARCO, Criteria, Delphi, Femoral head, Glucocorticoid, Osteonecrosis",

author = "Yoon, {Byung Ho} and Song, {Young Dong} and Jones, {Lynne C.} and Mont, {Michael A.} and Quanjun Cui and Koo, {Kyung Hoi}",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2024.",

year = "2024",

month = jan,

day = "1",

doi = "10.1007/978-981-97-5239-3_14",

language = "English",

isbn = "9789819752386",

pages = "123--128",

booktitle = "Osteonecrosis, Second Edition",

publisher = "Springer Singapore",

}

TY - CHAP

T1 - ARCO Classification Criteria of Glucocorticoid-Associated Osteonecrosis of the Femoral Head

AU - Yoon, Byung Ho

AU - Song, Young Dong

AU - Jones, Lynne C.

AU - Mont, Michael A.

AU - Cui, Quanjun

AU - Koo, Kyung Hoi

N1 - Publisher Copyright: © The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2024.

PY - 2024/1/1

Y1 - 2024/1/1

N2 - Glucocorticoids are commonly used for the treatment of various medical conditions such as autoimmune diseases, inflammatory conditions, and organ transplantation [1–3]. Long-term or high-dose usage of glucocorticoids has been associated with an increased risk of osteonecrosis, particularly in the femoral head [4–8]. Since 1957, when the first case of osteonecrosis of the femoral head (ONFH) after the use of glucocorticoid was reported, many human and animal studies identified the glucocorticoid use as a leading cause of ONFH [4–12].

AB - Glucocorticoids are commonly used for the treatment of various medical conditions such as autoimmune diseases, inflammatory conditions, and organ transplantation [1–3]. Long-term or high-dose usage of glucocorticoids has been associated with an increased risk of osteonecrosis, particularly in the femoral head [4–8]. Since 1957, when the first case of osteonecrosis of the femoral head (ONFH) after the use of glucocorticoid was reported, many human and animal studies identified the glucocorticoid use as a leading cause of ONFH [4–12].

KW - ARCO

KW - Criteria

KW - Delphi

KW - Femoral head

KW - Glucocorticoid

KW - Osteonecrosis

UR - http://www.scopus.com/inward/record.url?scp=105002519565&partnerID=8YFLogxK

U2 - 10.1007/978-981-97-5239-3_14

DO - 10.1007/978-981-97-5239-3_14

M3 - Chapter

AN - SCOPUS:105002519565

SN - 9789819752386

SP - 123

EP - 128

BT - Osteonecrosis, Second Edition

PB - Springer Singapore

ER -

ARCO Classification Criteria of Glucocorticoid-Associated Osteonecrosis of the Femoral Head

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this